Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ORO
|
||||
| Former ID |
DIB002359
|
||||
| Drug Name |
Anti-N3pG-Abeta antibody
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [524268] | ||
| Target and Pathway | |||||
| Target(s) | Amyloid beta A4 protein | Target Info | [550236] | ||
| KEGG Pathway | Notch signaling pathway | ||||
| Alzheimer's disease | |||||
| Reactome | Nuclear signaling by ERBB4 | ||||
| Degradation of the extracellular matrix | |||||
| Regulated proteolysis of p75NTR | |||||
| NRIF signals cell death from the nucleus | |||||
| Activated NOTCH1 Transmits Signal to the Nucleus | |||||
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
| EPH-ephrin mediated repulsion of cells | |||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.